Deputy Prime Minister Tatyana Golikova proposed to provide for the possibility of centralized procurement of expensive drugs for hospitals. She stated this at the presidium of the government's coordinating council to combat coronavirus, writes RIA Novosti. “We propose to consider the possibility of a centralized purchase of certain expensive drugs for the provision of medical [...]
The instruction should include information about the Syndrome of inadequate secretion of ADH, depression, hot flashes, anuria/oliguria, acute liver failure data source and details
In accordance with paragraph 2 of Article 3 of the Federal Law of December 27, 2019, No. 475-FZ "On Amendments to the Federal Law" On the Circulation of Medicines "and the Federal Law" On Amendments to the Federal Law "On the Circulation of Medicines", an updated (amended ) a list of interchangeable drugs. data source [...]
The Federal Service for Surveillance in Healthcare informs about the receipt of the information on the detection within the framework of inspections for federal state control (supervision) in the field of drug circulation FGBU "Information and Methodological Center for Expertise, Accounting and Analysis of the Circulation of Medical Products" of Roszdravnadzor (Khabarovsk branch) drug "Amiodarone, [...]
September 14th. /TASS/. The Minister of Health of the Russian Federation Mikhail Murashko said that 723 thousand Russian citizens with a view are under the supervision of doctors. "Today, 723 thousand citizens of the Russian Federation suffering from a new coronavirus infection are still under the supervision of medical workers," he said in an interview [...]
Information on erectile dysfunction, hypomagnesemia, hypochloremia, hypokalemia, hyponatremia should be included in the instructions (short medicinal product characteristics, PIL) of products containing indapamide. data source and details
In connection with the letter of the Federal State Budgetary Institution "Scientific Center for the Expertise of Medicinal Products" of the Ministry of Health of Russia dated 09.09.2021 No. 22592 (input No. 2-180129 dated 09.10.2021), the Department of State Regulation of Medicines Circulation informs Of the Russian Federation of medicinal products for medical use containing [...]
Added information on the possibility of developing serotonin syndrome when combined with Buprenorphine (based on the PRAC recommendation). 4.4. Special warnings and precautions for use Interaction with other drugs and other forms of interaction Information has been added on the possibility of postpartum hemorrhage during therapy with selective serotonin reuptake inhibitors (SSRIs) and serotonin and [...]
The Federal Service for Surveillance in Healthcare, as part of the execution of the state function of organizing and conducting pharmacovigilance, informs about the termination of the functioning of the e-mail domain @roszdravnadzor.ru. Currently, the @roszdravnadzor.gov.ru domain is operating, including email addresses for collecting information on pharmacovigilance such as pharm@ roszdravnadzor.gov.ru (for MA holders and [...]
After reviewing the available evidence and evaluating the evidence provided by the relevant Marketing Authorization Holder (MAH), PRAC agreed that the product information for Ponatinib should be updated to reflect the risk of panniculitis. data source and details
